wehewehe
ʻO kā mākou methyl 2-methoxy-4-aminobenzoate he mea koʻikoʻi i ka hana ʻana o lenvatinib, i hoʻohana ʻia e mālama i ka maʻi thyroid a me ka maʻi maʻi.He kuleana koʻikoʻi kēia hui waena i ka ʻoihana lāʻau lapaʻau no ka mea ʻo ia ke kumu kumu no ka synthesis o lenvatinib.
ʻO ka pūhui, nona ka helu CAS o 27492-84-8, ʻike ʻia no kona maʻemaʻe kiʻekiʻe a me ka hilinaʻi.Hana ʻia ia me ka hoʻohana ʻana i ka ʻenehana hou loa a me nā ʻano mana koʻikoʻi koʻikoʻi e hōʻoia i ka hoʻokō ʻana i nā kūlana ʻoihana kiʻekiʻe.Loaʻa kā mākou lenvatinib intermediate 2-methoxy-4-aminobenzoic acid methyl ester i nā pūʻulu a kūpono ia no ka hana lāʻau lapaʻau nui.
ʻO kā mākou methyl 2-methoxy-4-aminobenzoate he keʻokeʻo a keʻokeʻo keʻokeʻo crystalline pauka e hiki ke hoʻoheheʻe ʻia i nā mea hoʻoheheʻe organik.Loaʻa iā ia nā noi nui i ka ʻoihana lāʻau lapaʻau a ʻike ʻia no kona maʻemaʻe a me ka paʻa.Hoʻopili maikaʻi ʻia ka pūhui e hōʻoia i kona kūpaʻa i ka wā o ka mālama ʻana a me ka hoʻouna ʻana, e ʻae ana i kā mākou mea kūʻai e hilinaʻi i kona ʻano kūlike.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
![10- (2-Chloropyrimidin-4-yl) -6,7,8,9-tetrahydropyridino [1,2-a] indole 2035090-53-8](https://cdnus.globalso.com/jdkchemicals/10-2-Chloropyrimidin-4-yl-6789-tetrahydropyridino-12-a-indole.jpg)
